Beta-Endorphin Specifically Binds to Lung and Liver in Living Rats
Radioactive beta-endorphin accumulated specifically in the lung and liver — not other tissues — suggesting these organs have dedicated beta-endorphin receptors.
Quick Facts
What This Study Found
Radioactive beta-endorphin injected intravenously accumulated specifically in the lung and liver but not other tissues. Four lines of evidence confirmed this was specific receptor binding, not passive trapping.
First, adding excess unlabeled beta-endorphin reduced the labeled peptide in lung and liver.
Second, injecting unlabeled beta-endorphin via the femoral vein (which passes through the lungs first) rapidly increased blood levels of the pre-injected labeled peptide, displacing it from lung binding sites. Injection via the carotid artery (bypassing the lungs) did not have this effect.
Third, immunoreactive labeled peptide that had lost its receptor-binding ability did not accumulate in lung or liver.
Fourth, dynorphin (1-13) and ethylketocyclazocine (kappa agonist) displaced beta-endorphin from these sites, but DADLE (delta agonist) and naloxone (mu antagonist) did not. This pharmacological profile indicates kappa-type binding sites.
Key Numbers
How They Did This
Radiolabeled [125I-Tyr27]beta-endorphin injected intravenously into rats. Tissue-to-serum ratios measured. Displacement studies with selective opioid agonists and antagonists. HPLC-purified immunoreactive control peptide tested. Routes of injection varied to isolate lung-specific binding.
Why This Research Matters
The lung and liver as beta-endorphin binding sites was unexpected. These organs may serve as a peripheral opioid reservoir or clearance system. Lung kappa receptors could be involved in respiratory regulation and pain modulation.
The Bigger Picture
Non-classical opioid binding sites in the lung and liver could explain some systemic effects of endorphins beyond pain and mood — potentially affecting breathing regulation and metabolism.
What This Study Doesn't Tell Us
Tested in rats, not people. Radiolabeled peptide studies have technical artifacts. The functional significance of lung and liver binding was not determined. Only one time point (15 minutes) was studied.
Questions This Raises
- ?What is the function of lung beta-endorphin receptors?
- ?Do these non-classical receptors play a role in liver disease or respiratory regulation?
Trust & Context
- Key Stat:
- Lung and liver specific Beta-endorphin binding sites distinct from classical mu/delta/kappa receptors
- Evidence Grade:
- Preliminary animal study with four lines of evidence but function of binding sites unknown.
- Study Age:
- Published in 1988 — early evidence for non-classical peripheral opioid binding sites.
- Original Title:
- In vivo evidence for the specific binding of human beta-endorphin to the lung and liver of the rat.
- Published In:
- Biochemical pharmacology, 37(11), 2273-8 (1988)
- Authors:
- Sato, H(2), Sugiyama, Y, Sawada, Y, Iga, T, Hanano, M
- Database ID:
- RPEP-00091
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why would the lung have endorphin receptors?
The lung may use beta-endorphin to regulate breathing patterns, blood vessel tone, or immune responses. These non-classical receptors suggest functions beyond traditional pain and mood modulation.
Are these the same as brain opioid receptors?
No — these binding sites were not affected by drugs that block mu, delta, or kappa receptors, suggesting they are a distinct receptor type specific to peripheral organs.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00091APA
Sato, H; Sugiyama, Y; Sawada, Y; Iga, T; Hanano, M. (1988). In vivo evidence for the specific binding of human beta-endorphin to the lung and liver of the rat.. Biochemical pharmacology, 37(11), 2273-8.
MLA
Sato, H, et al. "In vivo evidence for the specific binding of human beta-endorphin to the lung and liver of the rat.." Biochemical pharmacology, 1988.
RethinkPeptides
RethinkPeptides Research Database. "In vivo evidence for the specific binding of human beta-endo..." RPEP-00091. Retrieved from https://rethinkpeptides.com/research/sato-1988-in-vivo-evidence-for
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.